MBL2 and COVID-19: These data show that polymorphisms in exon 1 of the MBL2 gene, associated with reduced protein levels, may be a genetic factor that promotes a significant contribution to the dysregulation of innate immune control and leads to the development of more severe manifestations of COVID-19.